Cargando…
Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826954/ https://www.ncbi.nlm.nih.gov/pubmed/29493662 http://dx.doi.org/10.3389/fendo.2018.00050 |
| _version_ | 1783302404209377280 |
|---|---|
| author | Nyström, Thomas Santos-Pardo, Irene Hedberg, Fredric Wardell, Johan Witt, Nils Cao, Yang Bojö, Leif Nilsson, Bo Jendle, Johan |
| author_facet | Nyström, Thomas Santos-Pardo, Irene Hedberg, Fredric Wardell, Johan Witt, Nils Cao, Yang Bojö, Leif Nilsson, Bo Jendle, Johan |
| author_sort | Nyström, Thomas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5826954 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-58269542018-02-28 Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study Nyström, Thomas Santos-Pardo, Irene Hedberg, Fredric Wardell, Johan Witt, Nils Cao, Yang Bojö, Leif Nilsson, Bo Jendle, Johan Front Endocrinol (Lausanne) Endocrinology Frontiers Media S.A. 2018-02-22 /pmc/articles/PMC5826954/ /pubmed/29493662 http://dx.doi.org/10.3389/fendo.2018.00050 Text en Copyright © 2018 Nyström, Santos-Pardo, Hedberg, Wardell, Witt, Cao, Bojö, Nilsson and Jendle. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Endocrinology Nyström, Thomas Santos-Pardo, Irene Hedberg, Fredric Wardell, Johan Witt, Nils Cao, Yang Bojö, Leif Nilsson, Bo Jendle, Johan Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study |
| title | Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study |
| title_full | Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study |
| title_fullStr | Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study |
| title_full_unstemmed | Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study |
| title_short | Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study |
| title_sort | corrigendum: effects on subclinical heart failure in type 2 diabetic subjects on liraglutide treatment vs. glimepiride both in combination with metformin: a randomized open parallel-group study |
| topic | Endocrinology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826954/ https://www.ncbi.nlm.nih.gov/pubmed/29493662 http://dx.doi.org/10.3389/fendo.2018.00050 |
| work_keys_str_mv | AT nystromthomas corrigendumeffectsonsubclinicalheartfailureintype2diabeticsubjectsonliraglutidetreatmentvsglimepiridebothincombinationwithmetforminarandomizedopenparallelgroupstudy AT santospardoirene corrigendumeffectsonsubclinicalheartfailureintype2diabeticsubjectsonliraglutidetreatmentvsglimepiridebothincombinationwithmetforminarandomizedopenparallelgroupstudy AT hedbergfredric corrigendumeffectsonsubclinicalheartfailureintype2diabeticsubjectsonliraglutidetreatmentvsglimepiridebothincombinationwithmetforminarandomizedopenparallelgroupstudy AT wardelljohan corrigendumeffectsonsubclinicalheartfailureintype2diabeticsubjectsonliraglutidetreatmentvsglimepiridebothincombinationwithmetforminarandomizedopenparallelgroupstudy AT wittnils corrigendumeffectsonsubclinicalheartfailureintype2diabeticsubjectsonliraglutidetreatmentvsglimepiridebothincombinationwithmetforminarandomizedopenparallelgroupstudy AT caoyang corrigendumeffectsonsubclinicalheartfailureintype2diabeticsubjectsonliraglutidetreatmentvsglimepiridebothincombinationwithmetforminarandomizedopenparallelgroupstudy AT bojoleif corrigendumeffectsonsubclinicalheartfailureintype2diabeticsubjectsonliraglutidetreatmentvsglimepiridebothincombinationwithmetforminarandomizedopenparallelgroupstudy AT nilssonbo corrigendumeffectsonsubclinicalheartfailureintype2diabeticsubjectsonliraglutidetreatmentvsglimepiridebothincombinationwithmetforminarandomizedopenparallelgroupstudy AT jendlejohan corrigendumeffectsonsubclinicalheartfailureintype2diabeticsubjectsonliraglutidetreatmentvsglimepiridebothincombinationwithmetforminarandomizedopenparallelgroupstudy |